Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens

Autor:	Annalisa Pezzi, Serena Rocchi, Marina Martello, Carolina Terragna, Beatrice Anna Zannetti, Katia Mancuso, Ilaria Rizzello, Lucia Pantani, Enrica Borsi, Nicoletta Testoni, Elena Zamagni, Michele Cavo, Annamaria Brioli, Giulia Marzocchi, Paola Tacchetti
Přispěvatelé:	Tacchetti, Paola, Cavo, Michele, Rocchi, Serena, Pezzi, Annalisa, Pantani, Lucia, Brioli, Annamaria, Testoni, Nicoletta, Terragna, Carolina, Zannetti, BEATRICE ANNA, Mancuso, Katia, Marzocchi, Giulia, Borsi, Enrica, Martello, Marina, Rizzello, Ilaria, Zamagni, Elena
Rok vydání:	2016
Předmět:	serum free light chain Male Cancer Research medicine.medical_specialty Salvage therapy Newly diagnosed Immunoglobulin light chain Gastroenterology Bortezomib 03 medical and health sciences 0302 clinical medicine Serum free Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Overall survival Biomarkers Tumor Humans Multiple myeloma Aged Neoplasm Staging Proportional Hazards Models Proportional hazards model business.industry Hematology Middle Aged medicine.disease Prognosis Surgery Treatment Outcome Oncology 030220 oncology & carcinogenesis escape Female Immunoglobulin Light Chains business Multiple Myeloma prognosi 030215 immunology medicine.drug
Zdroj:	Leukemialymphoma. 57(9)
ISSN:	1029-2403
Popis:	We retrospectively investigated the role of serial serum-free light chain (sFLC) evaluations in 150 multiple myeloma (MM) patients treated with first-line bortezomib-based regimens. Baseline sFLC ratio (sFLCR) identified three groups of patients - normal, lightly abnormal (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d21a7a1ec2f92d112b7826bb889b2ad2 https://pubmed.ncbi.nlm.nih.gov/26763357 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.